Planchais Cyril, Fernández Ignacio, Chalopin Benjamin, Bruel Timothée, Rosenbaum Pierre, Beretta Maxime, Dimitrov Jordan D, Conquet Laurine, Donati Flora, Prot Matthieu, Porrot Françoise, Planas Delphine, Staropoli Isabelle, Guivel-Benhassine Florence, Baquero Eduard, van der Werf Sylvie, Haouz Ahmed, Simon-Lorière Etienne, Montagutelli Xavier, Maillère Bernard, Rey Félix A, Guardado-Calvo Pablo, Nozach Hervé, Schwartz Olivier, Mouquet Hugo
Institut Pasteur, Université Paris Cité, INSERM U1222, Humoral Immunology Unit, 75015 Paris, France.
Institut Pasteur, Université Paris Cité, Structural Virology Unit, 75015 Paris, France.
iScience. 2024 Jun 22;27(7):110354. doi: 10.1016/j.isci.2024.110354. eCollection 2024 Jul 19.
Antibodies play a pivotal role in protecting from SARS-CoV-2 infection, but their efficacy is challenged by the continuous emergence of viral variants. In this study, we describe two broadly neutralizing antibodies cloned from the memory B cells of a single convalescent individual after infection with ancestral SARS-CoV-2. Cv2.3194, a resilient class 1 anti-RBD antibody, remains active against Omicron sub-variants up to BA.2.86. Cv2.3132, a near pan-Sarbecovirus neutralizer, targets the heptad repeat 2 membrane proximal region. When combined, Cv2.3194 and Cv2.3132 form a complementary SARS-CoV-2 neutralizing antibody cocktail exhibiting a local dose-dependent synergy. Thus, remarkably robust neutralizing memory B cell antibodies elicited in response to ancestral SARS-CoV-2 infection can withstand viral evolution and immune escape. The cooperative effect of such antibody combination may confer a certain level of protection against the latest SARS-CoV-2 variants.
抗体在预防新冠病毒感染中发挥着关键作用,但其效力受到病毒变体不断出现的挑战。在本研究中,我们描述了从一名感染原始新冠病毒的康复个体的记忆B细胞中克隆出的两种广泛中和抗体。Cv2.3194是一种具有弹性的1类抗受体结合域(RBD)抗体,对包括BA.2.86在内的奥密克戎亚变体仍保持活性。Cv2.3132是一种近乎泛沙贝科病毒中和剂,靶向七肽重复序列2膜近端区域。Cv2.3194和Cv2.3132组合时,形成一种互补的新冠病毒中和抗体鸡尾酒,表现出局部剂量依赖性协同作用。因此,针对原始新冠病毒感染产生的异常强大的中和记忆B细胞抗体能够抵御病毒进化和免疫逃逸。这种抗体组合的协同效应可能对最新的新冠病毒变体提供一定程度的保护。